HSBC Holdings’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Sell |
4,340
-4,118
| -49% | -$230K | ﹤0.01% | 2116 |
|
|
2025
Q1 | $405K | Buy |
8,458
+330
| +4% | +$15.8K | ﹤0.01% | 1753 |
|
|
2024
Q4 | $313K | Buy |
8,128
+2,259
| +38% | +$86.9K | ﹤0.01% | 2070 |
|
|
2024
Q3 | $262K | Sell |
5,869
-1,660
| -22% | -$74.2K | ﹤0.01% | 2070 |
|
|
2024
Q2 | $257K | Sell |
7,529
-105,358
| -93% | -$3.59M | ﹤0.01% | 2045 |
|
|
2024
Q1 | $3.27M | Sell |
112,887
-6,447
| -5% | -$187K | ﹤0.01% | 1028 |
|
|
2023
Q4 | $2.74M | Sell |
119,334
-434,971
| -78% | -$9.98M | ﹤0.01% | 1082 |
|
|
2023
Q3 | $9.17M | Sell |
554,305
-6,150
| -1% | -$102K | 0.01% | 735 |
|
|
2023
Q2 | $15.7M | Buy |
+560,455
| New | +$15.7M | 0.02% | 624 |
|